101. Recombinant human G-CSF-mobilized peripheral blood stem cells for second allogeneic transplant after bone marrow graft rejection in children.
- Author
-
Zecca M, Perotti C, Marradi P, Montagna D, Giorgiani G, Balter R, Prete L, and Locatelli F
- Subjects
- Anemia, Sickle Cell therapy, Bone Marrow Transplantation, Child, Child, Preschool, Female, Granulocyte Colony-Stimulating Factor therapeutic use, Humans, Recombinant Proteins therapeutic use, Anemia, Aplastic therapy, Graft Rejection, Hematopoietic Stem Cell Transplantation
- Abstract
Two children affected by severe aplastic anaemia and sickle cell anaemia rejected the allogeneic bone marrow transplantation from an HLA-matched unrelated volunteer and an HLA-identical sibling, respectively. In both cases a second transplant using granulocyte-colony stimulating factor (G-CSF) mobilized peripheral blood stem cells (PBSC) was performed. Donors were the HLA-haploidentical mother and the same HLA-identical sibling who was employed for the first marrow allograft, respectively. Treatment with G-CSF and PBSC collection were well tolerated. Both patients had engraftment of donor haemopoiesis and did not experience severe graft-versus-host disease. These cases confirm that PBSC transplant should be considered as a feasible treatment to reverse graft failure in paediatric patients.
- Published
- 1996
- Full Text
- View/download PDF